We are live on ! Find out more
RCW

Rheos Capital Works Portfolio holdings

AUM $1.5B
1-Year Est. Return 47.78%
This Fund
S&P 500
This Quarter Est. Return
+8.01%
1 Year Est. Return
+47.78%
3 Year Est. Return
+159.74%
5 Year Est. Return
+203.98%
10 Year Est. Return
AUM
$1.91B
AUM Growth
-$180M
Cap. Flow
-$288M
Cap. Flow %
-15.09%
Top 10 Hldgs %
36.06%
Holding
117
New
20
Increased
31
Reduced
22
Closed
19

Top Buys

Rank Stock Value
1
GS icon
Goldman Sachs
GS
+$29.8M
2
C icon
Citigroup
C
+$28.4M
3
GOOG icon
Alphabet (Google) Class C
GOOG
+$25.5M
4
CROX icon
Crocs
CROX
+$22.2M
5
HPE icon
Hewlett Packard
HPE
+$16.6M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$71.2M
2
NVDA icon
NVIDIA
NVDA
+$68.2M
3
RACE icon
Ferrari
RACE
+$42M
4
LLY icon
Eli Lilly
LLY
+$41.3M
5
VRT icon
Vertiv
VRT
+$39.6M

Sector Composition

Rank Sector Weight
1 Technology 32.18%
2 Consumer Discretionary 15.39%
3 Industrials 10.51%
4 Financials 10.28%
5 Healthcare 9.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HUM icon
76
Humana
HUM
$43.7B
$5.61M 0.29%
+15,000
New +$5.06M
KNSL icon
77
Kinsale Capital Group
KNSL
$8.45B
$5.55M 0.29%
14,400
ELV icon
78
Elevance Health
ELV
$84.8B
$5.42M 0.28%
+10,000
New +$5.29M
ISRG icon
79
Intuitive Surgical
ISRG
$133B
$5.34M 0.28%
12,000
-20,000
-63% -$7.97M
GTLS
80
DELISTED
Chart Industries
GTLS
$5.27M 0.28%
36,500
SMR icon
81
NuScale Power
SMR
$3.25B
$5.26M 0.28%
450,000
+200,000
+80% +$1.42M
HLI icon
82
Houlihan Lokey
HLI
$8.96B
$5.18M 0.27%
+38,400
New +$5.03M
TAP icon
83
Molson Coors Class B
TAP
$7.85B
$5.08M 0.27%
+100,000
New +$5.78M
AKRO
84
DELISTED
Akero Therapeutics
AKRO
$5.07M 0.27%
+216,000
New +$4.62M
ETN icon
85
Eaton
ETN
$174B
$4.7M 0.25%
15,000
-13,000
-46% -$4.2M
BTI icon
86
British American Tobacco
BTI
$128B
$4.64M 0.24%
+150,000
New +$4.56M
APH icon
87
Amphenol
APH
$212B
$4.58M 0.24%
+68,000
New +$4.29M
CME icon
88
CME Group
CME
$95.2B
$4.58M 0.24%
23,300
-45,500
-66% -$9.4M
CBOE icon
89
Cboe Global Markets
CBOE
$29.7B
$4.54M 0.24%
26,700
-54,700
-67% -$9.71M
ESAB icon
90
ESAB
ESAB
$5.75B
$4.41M 0.23%
46,666
VST icon
91
Vistra
VST
$47.4B
$4.3M 0.23%
+50,000
New +$4.18M
WOLF icon
92
Wolfspeed
WOLF
$1.31B
$4.04M 0.21%
177,500
LSCC icon
93
Lattice Semiconductor
LSCC
$18.2B
$3.91M 0.2%
67,400
LULU icon
94
lululemon athletica
LULU
$14B
$3.88M 0.2%
+13,000
New +$4.35M
COIN icon
95
Coinbase
COIN
$39.5B
$3.78M 0.2%
+17,000
New +$3.91M
LAZ icon
96
Lazard
LAZ
$4.26B
$3.05M 0.16%
+80,000
New +$3.12M
ACN icon
97
Accenture
ACN
$104B
$3.03M 0.16%
10,000
-15,000
-60% -$4.59M
AAPL icon
98
Apple
AAPL
$4.54T
-208,200
Closed -$35.7M
ADBE icon
99
Adobe
ADBE
$103B
-22,500
Closed -$11.4M
AMD icon
100
Advanced Micro Devices
AMD
$786B
-34,100
Closed -$6.16M

Similar funds

Rheos Capital Works's Q2 2024 Portfolio in Review

As of Q2 2024, Rheos Capital Works held 117 positions worth $1.91B, down 8.6% from $2.09B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Rheos Capital Works withdrew a net $288M in Q2 2024, closing 19 positions and reducing 22 holdings. Its most notable exit was Apple, an estimated $35.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 40% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Rheos Capital Works opened a new position in Goldman Sachs worth $30.8M.

  • Rheos Capital Works's largest Q2 2024 buy was Goldman Sachs: 68,000 shares worth $30.8M.
  • Rheos Capital Works added most to Alphabet (Google) Class C in Q2 2024, an estimated $25.5M increase.
  • Rheos Capital Works's biggest Q2 2024 reduction was Microsoft, cutting an estimated $71.2M.
  • Rheos Capital Works fully exited Apple in Q2 2024, selling an estimated $35.7M.
  • Rheos Capital Works's ten largest holdings make up 36% of its $1.91B portfolio in Q2 2024.
  • Rheos Capital Works opened 20 new positions and closed 19 in Q2 2024.
  • Rheos Capital Works's portfolio value fell 8.6% quarter-over-quarter to $1.91B.

Based on Rheos Capital Works's 13F filing for Q2 2024, filed 24 Jul 2024.